Xelevia is a medicine that contains the active substance sitagliptin. It is available as tablets (25, 50 and 100 mg). What is Xelevia used for? Xelevia is used in patients with type-2 diabetes to improve the control of blood glucose (sugar) levels. It is …

Xelevia is a medicine that contains the active substance sitagliptin. It is available as tablets (25, 50 and 100 mg). What is Xelevia used for? Xelevia is used in patients with type-2 diabetes to improve the control of blood glucose (sugar) levels. It is …

2022年7月8日 · XELEVIA contains the active ingredient sitagliptin. XELEVIA is a member of a class of medicines you take by mouth called DPP-4 inhibitors (dipeptidyl peptidase-4 inhibitors) that lowers blood sugar levels in adults with type 2 diabetes mellitus. XELEVIA is used to lower blood sugar levels in adults with type 2 diabetes mellitus.

Xelevia is a medicine that contains the active substance sitagliptin. It is available as tablets (25, 50 and 100 mg). What is Xelevia used for? Xelevia is used in patients with type 2 diabetes to improve the control of blood glucose (sugar) levels. It is …

2025年1月7日 · By inhibiting the DPP-4 enzyme, Xelevia increases the levels of two known active incretin hormones, glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). The incretins are part of an endogenous system involved in the physiologic regulation of glucose homeostasis.

For adult patients with type 2 diabetes mellitus, Xelevia is indicated to improve glycaemic control: as monotherapy: • in patients inadequately controlled by diet and exercise alone and for whom metformin is

2020年6月17日 · 研究发现，对于轻度肾功能损害 (内生肌酐清除率为30～50mL·min)患者，只需用药量的 1/2，对于重度肾功能损害 (内生肌酐清除率<30mL·min)患者，只需用药量的1/4。 与其它降糖药物合用时，西他列汀不会很明显的改变其它降糖药物的药动学途径，而其它降糖药物也不会明显改变西他列汀的代谢途径。 用药温馨提示：当您服用此药物时，需定期接受医疗专业人士的检查，以便随时针对其药效、副作用等情况进行监测。 本网站所包含的信息旨在为患者提供帮 …

Xelevia enthält den Wirkstoff Sitagliptin und gehört zu einer Klasse von Arzneimitteln, die bei der Zuckerkrankheit eingenommen werden. Diese Arzneimittelklasse wird als DPP-4-Hemmer (Dipeptidyl-Peptidase-4-Inhibitoren) bezeichnet und dient zur Blutzuckerregulierung bei zuckerkranken erwachsenen Patienten mit Typ-2-Diabetes.

For adult patients with type-2 diabetes mellitus, Xelevia is indicated to improve glycaemic control: as monotherapy: in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance; as dual oral therapy in combination with: metformin when diet and exercise plus ...

2022年8月19日 · Xelevia is a member of a class of medicines you take by mouth called DPP-4 inhibitors (dipeptidyl peptidase-4 inhibitors) that lowers blood sugar levels in patients with type 2 diabetes mellitus. Type 2 diabetes is also called non-insulin-dependent diabetes mellitus, or …